ELAN
Price
$22.55
Change
+$0.14 (+0.62%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
11.22B
23 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$15.96
Change
+$0.59 (+3.84%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
2.1B
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs PRGO

ELAN vs PRGO Comparison Chart in %
View a ticker or compare two or three
VS
ELAN vs. PRGO commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and PRGO is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ELAN with price predictions
Oct 13, 2026

Momentum Indicator for ELAN turns negative, indicating new downward trend

ELAN saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 64 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 50-day moving average for ELAN moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for ELAN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ELAN just turned positive on October 05, 2026. Looking at past instances where ELAN's MACD turned positive, the stock continued to rise in 36 of 48 cases over the following month. The odds of a continued upward trend are 75%.

Following a +2.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAN advanced for three days, in 173 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

ELAN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. ELAN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.703) is normal, around the industry mean (43.873). P/E Ratio (374.143) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (4.042) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.275) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for PRGO with price predictions
Oct 13, 2026

PRGO in +6.55% Uptrend, rising for three consecutive days on October 12, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PRGO advanced for three days, in 180 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on PRGO as a result. In 50 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.

The Moving Average Convergence Divergence (MACD) for PRGO just turned positive on October 12, 2026. Looking at past instances where PRGO's MACD turned positive, the stock continued to rise in 26 of 41 cases over the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 88 of 186 cases where PRGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 47%.

Bearish Trend Analysis

The 10-day RSI Indicator for PRGO moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 24 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

PRGO broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. PRGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.833) is normal, around the industry mean (43.873). PRGO's P/E Ratio (2818.000) is considerably higher than the industry average of (141.710). Projected Growth (PEG Ratio) (1.142) is also within normal values, averaging (2.152). PRGO's Dividend Yield (0.077) is considerably higher than the industry average of (0.005). P/S Ratio (0.454) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

FUNDAMENTALS RATINGS
ELAN vs PRGO: Fundamental Ratings
ELAN
PRGO
OUTLOOK RATING
1..100
485
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9298
PRICE GROWTH RATING
1..100
5737
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (92) in the Agricultural Commodities Or Milling industry. This means that PRGO’s stock grew somewhat faster than ELAN’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PRGO’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (92) in the Agricultural Commodities Or Milling industry is in the same range as PRGO (98) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's Price Growth Rating (37) in the Pharmaceuticals Other industry is in the same range as ELAN (57) in the Agricultural Commodities Or Milling industry. This means that PRGO’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's P/E Growth Rating (1) in the Agricultural Commodities Or Milling industry is in the same range as PRGO (2) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PRGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANPRGO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 6 days ago
67%
Bullish Trend 3 days ago
64%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 14 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
47%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (ELAN: $22.41 vs. PRGO: $15.37)
Brand notoriety: ELAN: Notable vs. PRGO: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 58% vs. PRGO: 67%
Market capitalization -- ELAN: $11.22B vs. PRGO: $2.1B
ELAN [@Pharmaceuticals: Generic] is valued at $11.22B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.1B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green while PRGO’s FA Score has 1 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRGO is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 5 bearish.
  • PRGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а -0.31% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +9.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.16%. For the same industry, the average monthly price growth was -5.18%, and the average quarterly price growth was +11.32%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 06, 2026.

PRGO is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ELAN
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
CAKE.X2.3011470.043966
+1.95%
PancakeSwap cryptocurrency
AUCTION.X3.5934330.015491
+0.43%
Bounce Token cryptocurrency
TROY.X0.000003N/A
N/A
TROY cryptocurrency
ZIL.X0.003450-0.000038
-1.10%
Zilliqa cryptocurrency
POLS.X0.060971-0.000768
-1.24%
Polkastarter cryptocurrency

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with PAHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-0.66%
PAHC - ELAN
51%
Loosely correlated
-1.66%
ZTS - ELAN
44%
Loosely correlated
-1.78%
SNDL - ELAN
39%
Loosely correlated
-0.85%
PRGO - ELAN
37%
Loosely correlated
-0.52%
SUPN - ELAN
34%
Loosely correlated
-1.87%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-0.52%
SUPN - PRGO
49%
Loosely correlated
-1.87%
ELAN - PRGO
37%
Loosely correlated
-0.66%
EVO - PRGO
35%
Loosely correlated
-1.82%
ALVO - PRGO
34%
Loosely correlated
-2.18%
PBH - PRGO
34%
Loosely correlated
-1.02%
More